insights_auto
Why is DHER34 down 2.77%?
Dive Deeperchevron_right
DHER34:BVMF
Danaher Corporation Bdr
R$39.32
arrow_downward
-2.77%(-1.12) 1D
Oct 7, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHER34...
Open
R$38.67
High
R$39.32
Low
R$38.67
Mkt. cap
153.60B
Avg. vol.
2.39K
Volume
54.00
52-wk high
R$45.87
52-wk low
R$27.94
Shares outstanding
702.99M
No. of employees
59K
Open
R$38.67
High
R$39.32
Low
R$38.67
Mkt. cap
153.60B
Avg. vol.
2.39K
Volume
54.00
52-wk high
R$45.87
52-wk low
R$27.94
Shares outstanding
702.99M
No. of employees
59K
News stories
From web sources and news partners
Quartz
·
8 hours ago
Danaher is launching an AI-powered autonomous lab for drug discovery
Investing.com
·
9 hours ago
Danaher stock rises 2% on AI-powered autonomous lab plans
Stock Titan
·
11 hours ago
A planned lab could make up to 10 times as many research tools each year as it scales.
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr